SOURCE: Millennium Healthcare Inc.

Millennium Healthcare Inc.

March 15, 2016 08:30 ET

Millennium Healthcare, Inc. Receives "Strong Buy" Recommendation From LJR Capital Management

MELVILLE, NY--(Marketwired - Mar 15, 2016) - Millennium Healthcare, Inc. (OTCQB: MHCC), a healthcare services and medical device distribution company, today announced that the Company has received a "Strong Buy" recommendation in a report published by LJR Capital Management. LJR Capital Management is an independent business consulting firm which works with investment bankers to provide small-to-medium sized companies with access to capital.

In the report released today, LJR Capital Management discusses Millennium's corporate strategy, management plans, and its position in the growing medical services sector. The report highlights Millennium's product line, including innovative, non-invasive products such as UroVal and VasoScan, stating, "These products provide physicians with timely and accurate diagnostic screening, and allows for more direct patient care, as well as new cash-flow streams, at a time when doctors are searching for new ways to generate revenues."

Additionally, the report covers Millennium's recently announced partnership with a specialty medical laboratory group to provide full-service, comprehensive lab services. The lab's complete list of services include providing collection supplies, transportation services, express turn-around, and comprehensive on-line patient reporting.

Along with Millennium's product and services footprint, the report outlines the Company's plans to expand geographically into the Gulf South region, sometimes known as the "Heart-Attack Belt" or "Stroke Belt." The Company is working on opening offices in Louisiana and Mississippi. A copy of the report will be available at under Millennium Healthcare.

About Millennium Healthcare Inc. (
Millennium Healthcare Inc., through its wholly owned operating subsidiaries, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting-edge medical devices focused primarily on preventive care through early detection. The Company also provides advanced billing and coding services, and practice development and management services. For more information, please visit

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains certain statements that may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

Contact Information